A Safety and Tolerability Study of GB301

Clinical trial NCT03865017 · UNKNOWN

Trial details

NCT number: NCT03865017
Sponsor: VTBIO Co. LTD
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2019-12-01
Primary completion: 2020-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.